Immunization

What pediatric health care providers should know about the 2022 Advisory Committee on Immunization Practices schedule updates.

Some parents are still hesitant about vaccinating their children.

A pilot program utilized student pharmacists, medical residents, and nurses to facilitate well-child visits.

There’s more to vaccines than just COVID-19.

Recent changes in regulations mean that pharmacists are able to administer vaccines to children as young as 3.

Multiple pharmaceutical companies are investigating the application of mRNA technology to develop vaccines that treat and prevent multiple conditions, from influenza to cancer and beyond.

Results of a recent preclinical study provide proof of concept that an mRNA HIV vaccine is safe, immunogenic, and induces CD4–T-cell responses.

For more than 70 years, vaccination has been a public health strategy for disease mitigation. Even in populations often considered “vulnerable”—children and pregnant women—vaccination is strongly recommended and commonly embraced.

Vaccines are important for everyone, but they’re critical for adults older than 65 years.

Five reasons why Shingrix is recommended for adults aged 50-plus.

Administered as an injection every other month, Apretude gives people at risk of contracting HIV a PrEP alternative to taking daily pills.

Do no harm, even though your patient might.

The Centers for Disease and Control and Prevention (CDC) has given their support for giving a COVID-19 booster to children aged 12 to 15 years.

The FDA approved a biologics license application for the tick-borne encephalitis (TBE) vaccine TICOVAC for individuals 1 year or older.

As trusted source of information for parents, pharmacists are a key part of the plan to distribute the COVID-19 vaccine to newly eligible children.

How to educate patients about the safety of receiving the influenza and COVID-19 vaccines at the same time.

Human papillomavirus (HPV) vaccination has significantly decreased the incidence and mortality of cervical cancer in girls and women between the ages of 15 and 24, according to a research letter in JAMA Pediatrics.

CDC data shown to overstate US vaccination rates; school-based cognitive behavioral therapy for overwhelmed children; Moderna to develop Omicron-specific COVID-19 booster dose.

Learn how the challenges and opportunities of the last year have impacted independent pharmacy professionals around the world.

The Johnson & Johnson vaccine is staying on the market, but the preference for the Pfizer and Moderna mRNA vaccines stems from concerns about the rare but real risk of blood clots from the J&J vaccine.

The company says a third dose of their COVID-19 vaccine is effective against the latest variant of the disease.

Questions continue to swirl around eligibility for these shots.

The US FDA has accepted a Priority Review of the pneumococcal 15-valent conjugate vaccine VAXNEUVANCE™ in children aged 17 years and younger.

PreHevbrio is the only 3-antigen vaccine for Hepatitis B approved for adults

Educate patients about the safety of receiving the seasonal influenza and COVID-19 vaccine at the same time.